Cargando…
Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors
BACKGROUND: Glyoxalase system is one of the defense cellular mechanisms that protect cells against endogenous harmful metabolites, mainly methylglyoxal (MG), through conversion of cytotoxic methylglyoxal into the non-toxic lactic acid. Glyoxalase system comprises of two enzymes glyoxalase I, glyoxal...
Autores principales: | Audat, Suaad Abdallah, Al-Balas, Qosay Ali, Al-Oudat, Buthina Abdallah, Athamneh, Mo’ad Jamil, Bryant-Friedrich, Amanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976160/ https://www.ncbi.nlm.nih.gov/pubmed/35378924 http://dx.doi.org/10.2147/DDDT.S356621 |
Ejemplares similares
-
Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators
por: Al-Oudat, Buthina Abdallah, et al.
Publicado: (2019) -
Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking
por: Audat, Suaad A., et al.
Publicado: (2020) -
Generation of the First Structure-Based Pharmacophore Model Containing a Selective “Zinc Binding Group” Feature to Identify Potential Glyoxalase-1 Inhibitors
por: Al-Balas, Qosay, et al.
Publicado: (2012) -
Novel Chrysin-De-Allyl PAC-1 Hybrid Analogues as Anticancer Compounds: Design, Synthesis, and Biological Evaluation
por: Al-Oudat, Buthina A., et al.
Publicado: (2020) -
Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
por: Al-Balas, Qosay A, et al.
Publicado: (2016)